Visual loss in uveitis of childhood

British Journal of Ophthalmology

Volumn 87, Issue 7, 2003, Pages 879-884

  De Boer, Joke ^a   Wulffraat, N ^b   Rothova, A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTIINFECTIVE AGENT; CORTICOSTEROID; CYCLOSPORIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ARTICLE; BLINDNESS; CATARACT; CHILD; CHILDHOOD DISEASE; CHORIORETINITIS; CHORIORETINOPATHY; CLINICAL FEATURE; DATA ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; EYE INFLAMMATION; EYE SURGERY; FEMALE; HUMAN; IDIOPATHIC DISEASE; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; ONSET AGE; OPTIC NERVE DISEASE; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETINA MACULA LUTEA; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCAR FORMATION; SECONDARY GLAUCOMA; SEX RATIO; SYSTEMIC DISEASE; TOXOPLASMA; TREATMENT INDICATION; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; BLINDNESS; CATARACT; CHILD; CHILD, PRESCHOOL; CHOROIDITIS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; PROGNOSIS; RETINITIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOXOPLASMOSIS; UVEITIS; VISUAL ACUITY;

EID: 0038461042     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.7.879     Document Type: Article

References (54)

1. Nussenblatt RB. The natural course of uveitis. Int Ophthalmol 1990;141:303-8.
2. Rothova A, Suttorp-Schulten MSA, Treffers WF, et al. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996;80:332-6.
3. Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol 1992;76:137-41.
4. McCannel CA, Holland G N, Helm CJ, et al. Causes of uveitis in the general practice of ophthalmology. Am J Ophthalmol 1996;121:35-46.
5. Perkins ES. Patterns of uveitis in children. Br J Ophthalmol 1966;50:169-85.
6. Kimura SJ, Hogan MJ, Thygeson P. Uveitis in children. Arch Ophthalmol 1954;51:80-8.
7. Kanski JJ, Shun-Shin A. Systematic uveitis syndromes in childhood; an analysis of 340 cases. Ophthalmology 1984;91:1247-52.
8. Tugal-Tutkun I, Harvikova K, Power WJ, et al. Changing patterns in uveitis of childhood. Ophthalmology 1996;103:375-83.
9. Tamesis RR, Rodriguez A, Christen WG, et al. Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease. Ophthalmology 1996;103:768-75.
10. Santamaria JII. Steroidal agents: their systemic and ocular complication. Ocular Inflamm Ther 1983;1:19-26.
11. Kilmartin DJ, Forrester JV, Dick AD. Cyclosporin A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol 1998;82:737-42.
12. Hemady RK, Baer JC, Foster CS. Immunosuppressive drugs in the management of progressive corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis. Int Ophthalmol Clin 1992;32:241-52.
13. Ramadan A, Nussenblatt R. Cytotoxic agents in ocular inflammation. Ophthalmol Clin North Am 1997;10:337-87.
14. Giannini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis. N Engl J Med 1992;326:1043-9.
15. Gerloni V, Cimaz R, Gattinara M. Efficacy and safety profile of cyclosporin A in the treatment of uvenire chronic (idiopathic) arthritis. Results of a 10-year prospective study. Rheumatology 2001;40:907-13.
16. Dana MR, Merayo-Lloves J, Schaumberg DA, et al. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology 1997; 104:236-44.
17. Kanski JJ. Juvenile arthritis and uveitis. Surv Ophthalmol 1990;34:253-67.
18. Hooper PL, Rao NA, Smith RE. Cataract extraction in uveitis patients. Surv Ophthalmol 1990;35:120-44.
19. Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology 1987;94:1242-8.
20. Kanski JJ. Lensectomy for complicated cataract in juvenile chronic iridoclyclitis. Br J Ophthalmol 1992;76:72-5.
21. Fox JGM, Flynn HW, Davis Jr JL, et al. Causes of reduced visual acuity on long-term follow-up after cataract extraction in patients with uveitis and juvenile rheumatoid arthritis. Am J Ophthalmol 1992;114:708-14.
22. Edelsten C, Lee V, Bentley CR, et al. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol 2002;86:51-56.
23. Cunningham ET Jr. Uveitis in children. Ocular Immunol Inflamm 2000;8:251-61.
24. Bloch-Michel E, Nussenblatt RB. International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987;103:234-5.
25. Boer JH de, Verhagen C, Bruinenberg M, et al. Serological and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol 1996;121:650-8.
26. Berntson L, Fasth A, Andersson-Gare B, et al. Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism. J Rheumatol 2001;28:2737-43.
27. Krumrey-Langkammerer M, Hafner R. Evaluation of the ILAR criteria for juvenire idiopathic arthritis.J Rheumatol 2001;28:2544-7.
28. Holland GN, O'Connor R, Belfort R, et al. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St Louis: Mosby-Year Book, 1996:1183-223.
29. Kraut JA, McCabe CP. The problem of low vision. Definition and common problems. In: Albert DM, Jakobiec FA, eds. Principles and practice of ophthalmology. Philadelphia: WB Saunders, 1994;5:3664-6.
30. Foster CS, Havlrikova K, Baltatzis S, et al. Secundary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Acta Ophthalmol Scand 2000;78:576-9.
31. Välimäki J, Airaksinen J, Tuulonen A. Molteno implantation for secondary glaucoma in juvenile rheumatoid arthritis. Arch Ophthalmol 1997;115:1253-6.
32. Pinchoff BS, Ellis FD, Helveston EM, et al. Cystoid macular edema in pediatric aphakia. J Pediatr Ophthalmol Strabismus 1988;25:240-3.
33. Rao SK, Ravishankar K, Sitalakshmi G, et al. Cystoid macular edema after pediatric intraocular lens implantation: fluorescein angioscopy results and literature review. J Cataract Refract Surg 2001;27:432-6.
34. Morgan KS, Franklin RM. Oral fluorescein angioscopy in aphakic children. J Pediatr Ophthalmol Strabismus 1984;21:33-6.
35. Schulman J, Peyman GA, Raichand M, et al. Aphakic cystoid macular edema in children after vitrectomy for anterior segment injuries. Ophthalmic Surg 1983;14:848-51.
36. Poer DV, Helveston EM, Ellis FD. Aphakic cystoid macular edema in children. Arch Ophthalmol 1981;99:249-52.
37. American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology. Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 1993;92:295-6.
38. Fink CW, Cimaz R. Early onset sarcoidosis: not a benign disease. J Rheumatol 1977;24:174-7.
39. Okada AO, Foster CS. Posterior uveitis in the pediatric population. Int Ophthalmol Clin 1992;32:121-52.
40. Sadiq S, Gregson RMC, Downes RN. The CINCA syndrome: a rare cause of uveitis in childhood. J Pediatr Ophthalmol Strabismus 1996;33:59-64.
41. Dolffus H, Hafner R, Hofmann HM, et al. Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome. Arch Ophthalmol 2000;118:1386-92.
42. Prieur A. Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome. Arch Ophthalmol 2000;118:1386-92.
43. Stafford WR, Yanoff M, Parnell BL. Retinoblastomas initially misdiagnosed as primary ocular inflammations. Arch Ophthalmol 1969;82:771-3.
44. Vaile JH, Dyke L, Kherani R, et al. Is high titre ANA specific for connective tissue disease? Clin Exp Rheumatol 2000;18:433-8.
45. Perilloux BC, Shetty AK, Leiva LE, et al. Antinuclear antibody (ANA) and ANA profile tests in children with autoimmune disorders: a retrospective study. Clin Rheumatol 2000;19:200-3.
46. Pelletier J, Ali Cherif A. Multiple sclerosis plus": leukoencephalopathies at the frontiers of internal. Rev Med Interne 2000;21:1104-13.
47. Baarsma GS, La Hey E, Glassius, et al. The predictive value of serum angiotensin converting enzyme and lysozyme levels in the diagnosis of ocular sarcoidosis. Am J Ophthalmol 1987;104:211-7.
48. Samson CM, Waheed N, Baltatzis S, et al. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology 2001;108:1134-9.
49. Weiss AH, Wallace CA, Sherry DD. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. J Pediatr 1998;133:266-8.
50. Rose CD, Singsen BH, Eichenfeld AH, et al. Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr 1990;117:653-9.
51. Smith JR, Levinson RD, Holland GN, et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 2001;45:252-7.
52. Reiff A, Takei S, Sadeghi S, et al. Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum 2001;44:1411-15.
53. Boumpas DT, Kritikos HD, Daskalakis NG. Perspective on future therapy of vasculitis. Curr Rheumatol Rep 2000;2:423-9.
54. Wulffraat N, van Royen A, Bierings M, et al. Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 1999;35:550-3.